Engineered Cellular Vesicles Displaying Glycosylated Nanobodies for Cancer Immunotherapy

被引:10
作者
Wu, Jicheng [1 ,4 ]
Lu, Hailin [2 ]
Xu, Ximing [4 ]
Rao, Lang [1 ]
Ge, Yun [2 ,3 ]
机构
[1] Inst Biomed Hlth Technol & Engn, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China
[2] Inst Chem Biol, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China
[3] Peking Univ, Sch Chem Biol & Biotechnol, Shenzhen Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China
[4] Wuhan Univ, Renmin Hosp, Canc Ctr, Wuhan 430060, Peoples R China
基金
中国国家自然科学基金;
关键词
Nanobody; Glycosylation; Vesicles; Cancer Immunotherapy; HEMATOPOIETIC STEM-CELLS; HIGH-MANNOSE; ANTIBODIES; GLYCANS; CD47;
D O I
10.1002/anie.202404889
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Immune checkpoint blockade targeting the CD47/SIRP alpha axis represents an alluring avenue for cancer immunotherapy. However, the compromised efficacy and safety concerns in vivo of conventional anti-CD47 antibodies impede their wide clinical applications. Here we introduced a single type of high-mannose glycans into the nanobody against CD47 (HM-nCD47) and subsequently displayed HM-nCD47 on cellular vesicles (CVs) for enhanced cancer immunotherapy. In this platform, the CVs significantly improved the circulation time of HM-nCD47-CVs, the nCD47 enabled the blockade of the CD47/SIRP alpha axis, and the HM enhanced recognition of mannose-binding lectin, all synergistically activating the macrophage-mediated antitumor immunity. In both subcutaneous and metastatic murine tumor models, the HM-nCD47-CVs possessed significantly extended half-lives and increased accumulation at the tumor site, resulting in a remarkable macrophage-dependent inhibition of tumor growth, a transcriptomic remodeling of the immune response, and an increase in survival time. By integrating the chemical biology toolbox with cell membrane nanotechnology, the HM-nCD47-CVs represent a new immunotherapeutic platform for cancer and other diseases.
引用
收藏
页数:11
相关论文
共 52 条
[1]   Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition [J].
Ai, Xiangzhao ;
Wang, Dan ;
Honko, Anna ;
Duan, Yaou ;
Gavrish, Igor ;
Fang, Ronnie H. ;
Griffiths, Anthony ;
Gao, Weiwei ;
Zhang, Liangfang .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (42) :17615-17621
[2]  
BHATTACHARYYA L, 1987, J BIOL CHEM, V262, P1288
[3]   Blood Collection Tubes Influence Serum Ficolin-1 and Ficolin-2 Levels [J].
Brady, Allison M. ;
Spencer, Brady L. ;
Falsey, Ann R. ;
Nahm, Moon H. .
CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (01) :51-55
[4]   Cell-based glycan arrays for probing glycan-glycan binding protein interactions [J].
Briard, Jennie Grace ;
Jiang, Hao ;
Moremen, Kelley W. ;
Macauley, Matthew Scott ;
Wu, Peng .
NATURE COMMUNICATIONS, 2018, 9
[5]   The mannose receptor ligands and the macrophage glycome [J].
Cummings, Richard D. .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2022, 75
[6]   Emerging Principles for the Therapeutic Exploitation of Glycosylation [J].
Dalziel, Martin ;
Crispin, Max ;
Scanlan, Christopher N. ;
Zitzmann, Nicole ;
Dwek, Raymond A. .
SCIENCE, 2014, 343 (6166) :37-+
[7]   Siglecs as Immune Cell Checkpoints in Disease [J].
Duan, Shiteng ;
Paulson, James C. .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38, 2020, 38 :365-395
[8]   Engineered Bacterial Outer Membrane Vesicles as Controllable Two-Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy [J].
Feng, Qingqing ;
Ma, Xiaotu ;
Cheng, Keman ;
Liu, Guangna ;
Li, Yao ;
Yue, Yale ;
Liang, Jie ;
Zhang, Lizhuo ;
Zhang, Tianjiao ;
Wang, Xinwei ;
Gao, Xiaoyu ;
Nie, Guangjun ;
Zhao, Xiao .
ADVANCED MATERIALS, 2022, 34 (40)
[9]   Naturally occurring glycan forms of human immunoglobulins G1 and G2 [J].
Flynn, Gregory C. ;
Chen, Xiaoyu ;
Liu, Y. Diana ;
Shah, Bhavana ;
Zhang, Zhongqi .
MOLECULAR IMMUNOLOGY, 2010, 47 (11-12) :2074-2082
[10]   A journey through the lectin pathway of complementMBL and beyond [J].
Garred, Peter ;
Genster, Ninette ;
Pilely, Katrine ;
Bayarri-Olmos, Rafael ;
Rosbjerg, Anne ;
Ma, Ying Jie ;
Skjoedt, Mikkel-Ole .
IMMUNOLOGICAL REVIEWS, 2016, 274 (01) :74-97